# FDA Inspection 1012572 - McLaren Health Care Corporate Institutional Review Board - April 21, 2017

Source: https://www.keypedia.com/records/fda_inspections/mclaren-health-care-corporate-institutional-review-board/3c32e772-3b65-4091-888a-cb791dde5418
Source feed: FDA_Inspections

> FDA Inspection 1012572 for McLaren Health Care Corporate Institutional Review Board on April 21, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1012572
- Company Name: McLaren Health Care Corporate Institutional Review Board
- Inspection Date: 2017-04-21
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 789660 - 2012-07-03](https://www.keypedia.com/records/fda_inspections/mclaren-health-care-corporate-institutional-review-board/32b03f45-690e-438b-b9fe-fb9258b05734)
- [FDA Inspection 661012 - 2010-04-08](https://www.keypedia.com/records/fda_inspections/mclaren-health-care-corporate-institutional-review-board/b5b7b861-9c00-4d3f-bde5-72be9d9f2a0d)

Company: https://www.keypedia.com/companies/mclaren-health-care-corporate-institutional-review-board/f391d051-5e0b-4b38-926f-e0a43849a9c0

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c